NIST's research helps ensure American leadership of the bioeconomy by accelerating the transition of cell-based manufacturing processes and products from R&D into the marketplace through quantitative measurements, reference materials, standards and data.
With today’s biotechnology, we can use living cells as factories for products like food, fuels and medicines. Live cell and gene therapies, and regenerative medicine, are poised to revolutionize health care. Live microbial therapeutics are under development as the next class of clinical treatments. We can also make new kinds of sensors to rapidly detect disease outbreaks and biological weapons.
While the science of engineering cells has progressed, the American bioeconomy still struggles to design cell-based products from scratch and develop processes to manufacture them consistently at industrial scales. Unlike a traditional production line, living cells are always changing and difficult to control.
NIST scientists are addressing these issues by:
- working closely with industry to make measurement solutions for real-world development and manufacturing environments
- giving researchers and manufacturers measurement tools and methods they can use to compare and reproduce results, which speeds innovation, and ensure the product consistency needed to get clearance by regulators on the way to market
- helping researchers, manufacturers, regulators and clinicians make measurements that can be traced back to trusted NIST products, providing confidence in test results